Original Research

Published on 06 Oct 2022

Immunotherapy improves disease prognosis by affecting the tumor microenvironment: A bibliometric study

in Cancer Immunity and Immunotherapy

Xin Wu
Zhen Deng
Qiangqiang Zhao

Frontiers in Immunology

doi 10.3389/fimmu.2022.967076

4,515 views
5 citations

Mini Review

Published on 06 Oct 2022

Advances in CAR T-cell therapy in bile duct, pancreatic, and gastric cancers

in Cancer Immunity and Immunotherapy

Qiang Feng
Baozhen Sun
Tianyi Xue
Rong Li
Chao Lin
Yongjian Gao
Liqun Sun
Yue Zhuo
Dongxu Wang

Frontiers in Immunology

doi 10.3389/fimmu.2022.1025608

9,657 views
2 citations

Original Research

Published on 06 Oct 2022

The established chemokine-related prognostic gene signature in prostate cancer: Implications for anti-androgen and immunotherapies

in Cancer Immunity and Immunotherapy

Lei Chen
Yi Zheng
Changqin Jiang
Cheng Yang
Li Zhang
Chaozhao Liang

Frontiers in Immunology

doi 10.3389/fimmu.2022.1009634

2,706 views
4 citations

Case Report

Published on 06 Oct 2022

A durable response to programmed cell death 1 blockade in a multidrug-resistant recurrent ovarian cancer patient with HLA-B44 supertype: A case report

in Cancer Immunity and Immunotherapy

Xukai Luo
Yating Sun
Jiajia Li
Qidi Jiang
Lei Yuan
Ting Li
Mo Chen
Liangqing Yao

Frontiers in Immunology

doi 10.3389/fimmu.2022.951422

1,775 views
1 citation

Original Research

Published on 06 Oct 2022

Turning up a new pattern: Identification of cancer-associated fibroblast-related clusters in TNBC

in Cancer Immunity and Immunotherapy

Jindong Xie
Shaoquan Zheng
Yutian Zou
Yuhui Tang
Wenwen Tian
Chau-Wei Wong
Song Wu
Xueqi Ou
Wanzhen Zhao
Manbo Cai

Frontiers in Immunology

doi 10.3389/fimmu.2022.1022147

3,448 views
26 citations

Original Research

Published on 06 Oct 2022

Molecular subtypes based on Wnt-signaling gene expression predict prognosis and tumor microenvironment in hepatocellular carcinoma

in Cancer Immunity and Immunotherapy

Weifeng Xu
Caiyun Nie
Huifang Lv
BeiBei Chen
Jianzheng Wang
Saiqi Wang
Jing Zhao
Yunduan He
Xiaobing Chen

Frontiers in Immunology

doi 10.3389/fimmu.2022.1010554

2,016 views
2 citations

Review

Published on 06 Oct 2022

Exosomes in the tumor microenvironment: Promoting cancer progression

in Cancer Immunity and Immunotherapy

Ye Jin
Jianming Xing
Kejin Xu
Da Liu
Yue Zhuo

Frontiers in Immunology

doi 10.3389/fimmu.2022.1025218

2,892 views
5 citations

Original Research

Published on 06 Oct 2022

Identifying a novel ferroptosis-related prognostic score for predicting prognosis in chronic lymphocytic leukemia

in Cancer Immunity and Immunotherapy

Bihui Pan
Yue Li
Zhangdi Xu
Yi Miao
Hua Yin
Yilin Kong
Xinyu Zhang
Jinhua Liang
Yi Xia
Li Wang

Frontiers in Immunology

doi 10.3389/fimmu.2022.962000

3,198 views
5 citations

Original Research

Published on 06 Oct 2022

A novel cell senescence-related IncRNA survival model associated with the tumor immune environment in colorectal cancer

in Cancer Immunity and Immunotherapy

Chengfei Xu
Fanghan Li
Zilin Liu
Chuanjing Yan
Jiangwei Xiao

Frontiers in Immunology

doi 10.3389/fimmu.2022.1019764

2,249 views
1 citation

Original Research

Published on 06 Oct 2022

Immune infiltration landscape on prognosis and therapeutic response and relevant epigenetic and transcriptomic mechanisms in lung adenocarcinoma

in Cancer Immunity and Immunotherapy

Liangming Zhang
Biwang Jiang
Zhuxiang Lan
Chaomian Yang
Yien Yao
Jie Lin
Qiu Wei

Frontiers in Immunology

doi 10.3389/fimmu.2022.983570

2,885 views
2 citations

Original Research

Published on 06 Oct 2022

Tumor microenvironment features decipher the outperformance of neoadjuvant immunochemotherapy over chemotherapy in resectable non-small cell lung cancer

in Cancer Immunity and Immunotherapy

Wenhan Cai
Miao Jing
Yajun Gu
Ting Bei
Xiaochen Zhao
Shiqing Chen
Jiaxin Wen
Jie Gao
Chongchong Wu
Zhiqiang Xue

Frontiers in Immunology

doi 10.3389/fimmu.2022.984666

3,012 views
2 citations

Original Research

Published on 06 Oct 2022

Pulsed radiotherapy to mitigate high tumor burden and generate immune memory

in Cancer Immunity and Immunotherapy

Duygu Sezen
Hampartsoum B. Barsoumian
Kewen He
Yun Hu
Qi Wang
Chike O. Abana
Nahum Puebla-Osorio
Ethan Y. Hsu
Mark Wasley
Fatemeh Masrorpour

Frontiers in Immunology

doi 10.3389/fimmu.2022.984318

2,028 views
1 citation

Case Report

Published on 06 Oct 2022

Case report: A successful re-challenge report of GLS-010 (Zimberelimab), a novel fully humanized mAb to PD-1, in a case of recurrent endometrial cancer

in Cancer Immunity and Immunotherapy

Yeshan Chen
Ai Huang
Qin Yang
Jing Yu
Guiling Li

Frontiers in Immunology

doi 10.3389/fimmu.2022.987345

1,729 views
5 citations

Review

Published on 06 Oct 2022

Target tumor microenvironment by innate T cells

in Cancer Immunity and Immunotherapy

Yan-Ruide Li
Matthew Wilson
Lili Yang

Frontiers in Immunology

doi 10.3389/fimmu.2022.999549

5,937 views
10 citations

Original Research

Published on 06 Oct 2022

Efficacy and safety of universal (TCRKO) ARI-0001 CAR-T cells for the treatment of B-cell lymphoma

in Cancer Immunity and Immunotherapy

Noelia Maldonado-Pérez
María Tristán-Manzano
Pedro Justicia-Lirio
Elena Martínez-Planes
Pilar Muñoz
Kristina Pavlovic
Marina Cortijo-Gutiérrez
Carlos Blanco-Benítez
María Castella
Manel Juan

Frontiers in Immunology

doi 10.3389/fimmu.2022.1011858

4,424 views
4 citations

Review

Published on 06 Oct 2022

Prospective approaches to enhancing CAR T cell therapy for glioblastoma

in Cancer Immunity and Immunotherapy

Sun Il Choi
Jinlong Yin

Frontiers in Immunology

doi 10.3389/fimmu.2022.1008751

3,105 views
4 citations

Navigation group

Articles

Immunotherapy improves disease prognosis by affecting the tumor microenvironment: A bibliometric study

Advances in CAR T-cell therapy in bile duct, pancreatic, and gastric cancers

The established chemokine-related prognostic gene signature in prostate cancer: Implications for anti-androgen and immunotherapies

A durable response to programmed cell death 1 blockade in a multidrug-resistant recurrent ovarian cancer patient with HLA-B44 supertype: A case report

Turning up a new pattern: Identification of cancer-associated fibroblast-related clusters in TNBC

Molecular subtypes based on Wnt-signaling gene expression predict prognosis and tumor microenvironment in hepatocellular carcinoma

Exosomes in the tumor microenvironment: Promoting cancer progression

Identifying a novel ferroptosis-related prognostic score for predicting prognosis in chronic lymphocytic leukemia

A novel cell senescence-related IncRNA survival model associated with the tumor immune environment in colorectal cancer

Immune infiltration landscape on prognosis and therapeutic response and relevant epigenetic and transcriptomic mechanisms in lung adenocarcinoma

Tumor microenvironment features decipher the outperformance of neoadjuvant immunochemotherapy over chemotherapy in resectable non-small cell lung cancer

Pulsed radiotherapy to mitigate high tumor burden and generate immune memory

Case report: A successful re-challenge report of GLS-010 (Zimberelimab), a novel fully humanized mAb to PD-1, in a case of recurrent endometrial cancer

Target tumor microenvironment by innate T cells

Efficacy and safety of universal (TCRKO) ARI-0001 CAR-T cells for the treatment of B-cell lymphoma

Prospective approaches to enhancing CAR T cell therapy for glioblastoma